ROYAL BANK OF CANADA - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 29 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$0148
-52.4%
0.00%
Q2 2023$0
-100.0%
311
-85.5%
0.00%
Q3 2020$6,000
-14.3%
2,152
+0.4%
0.00%
Q2 2020$7,0002,143
+1848.2%
0.00%
Q1 2020$0
-100.0%
110
-38.2%
0.00%
Q3 2019$1,000178
+8800.0%
0.00%
Q3 2018$02
-33.3%
0.00%
Q3 2017$0
-100.0%
3
-100.0%
0.00%
Q2 2013$36,0007,0130.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q4 2020
NameSharesValueWeighting ↓
Sterling Financial Planning, Inc. 22,031$46,0000.03%
BERKSHIRE ASSET MANAGEMENT LLC/PA 189,048$392,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,655$595,0000.01%
Renaissance Technologies 622,228$1,291,0000.00%
ACADIAN ASSET MANAGEMENT LLC 188,164$390,0000.00%
Oakworth Capital, Inc. 3,052$6,0000.00%
BlackRock Inc. 140,248$292,0000.00%
Citadel Advisors 32,300$67,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 28,900$60,0000.00%
TWO SIGMA ADVISERS, LP 34,592$72,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders